Operational Readiness and Adaptable Project Management Built a Repeatable Early-Phase Oncology Study Model
|
Precision Medicine Group joins McKesson's Oncology & Multispecialty segment. Read more in McKesson Business Highlights.
In 2018, Precision's position as a prominent global CRO with a robust European footprint was strengthened through the acquisition of Argint International, a premier CRO specializing in Central and South-Eastern Europe.
Our strategic presence in Hungary, Poland, Romania, Slovakia, and Serbia facilitates access to a diverse patient pool, expediting patient recruitment. This coupled with a well-established clinical research environment and favorable regulatory ecosystem, delivers a streamlined trial experience.
Historically, difficult recruitment, delayed site initiation, and inadequate patient retention have significantly contributed to unsatisfactory trial results. The inception of the Precision Site Network aimed to address precisely these challenges by bringing together top-performing sites and experienced investigators, who are dedicated to improving patient outcomes.
With Precision’s clinical trial services, data science, and specialty lab services across Europe, we deliver a truly integrated global trial experience.
Our regional team’s expertise is second to none in running successful trials across Europe. This exceptional team of clinical professionals, in-country project managers and regulatory specialists, are well-versed in the regional regulatory, clinical and cultural landscape, and are deeply invested in your clinical program at every stage.
Chris Ingram
Executive Director, Regulatory Affairs, Europe
Katie McGuire
Senior Vice President, Regulatory and Site Start-Up
Frances Murphy
Regional Vice President, Clinical Business Solutions, EU & APAC
Simon Fleming
Executive Vice President
Precision's worldwide footprint is the cornerstone of our agility and adaptability. Tailored delivery models for your program, striking the perfect balance between onsite and offshore teams for optimized efficiency.
Stay ahead with the latest insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies for running successful clinical trials in Europe.
Discover
Discover
Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.
Award-winning CRO with deep oncology and rare disease expertise
Discover Explore
Exceptional translational and biomarker sciences with global central lab services
Learn how Precision’s European CRO services can help advance your clinical development program.
Executive Director, Regulatory Affairs, Europe
Chris Ingram, BSc (Hons) is Head of Regulatory Consultancy (Europe) for Precision for Medicine. Chris received his BSc(Hons) in immunology and pharmacology from the University of Strathclyde and has since spent over 21 years working in regulatory affairs with a focus on clinical development. Chris’ regulatory expertise covers clinical development across all phases, regulatory strategy, marketing authorisations, scientific advice, orphan drug designation and paediatric investigation plans across a wide variety of therapeutic areas, including but not limited to, oncology, CNS, metabolic, endocrinology, analgesia and cardiovascular.
Senior Vice President, Regulatory and Site Start-Up
Seasoned pharma leader with extensive expertise in oncology drug development and early phase clinical development. Veteran across multiple therapeutic indications in a wide range of multi-country, full-service studies through every phase. Strong communicator and trained executive coach who thrives on change and excels under pressure.
Regional Vice President, Clinical Business Solutions, EU & APAC
Frances Murphy is a leading authority in clinical CROs, focused on client services and regional growth implementation. Murphy is a dedicated proponent of harnessing truly personalized medicine to develop more effective treatments for patients and brings a high ethical standard to discussions and values transparency and collaboration.
Executive Vice President
Veteran of the pharmaceutical industry, fluent in all aspects of clinical trial management, including business development, strategic operations, process improvement, technology implementation and finance. Special focus on global quality management, data management, biostatistics and statistical programming operations.